RUS  ENG
Full version
JOURNALS // Mendeleev Communications // Archive

Mendeleev Commun., 2020 Volume 30, Issue 1, Pages 106–108 (Mi mendc1116)

This article is cited in 9 papers

Communications

Tubuloclustin analogues with ether moiety: synthesis and evaluation of tubulin clustering and antimitotic activity in cancer cells

N. A. Zefirovab, L. Gädertc, A. R. Fatkulina, V. M. Shibileva, G. M. Butovd, V. M. Mokhove, S. A. Kuznetsovc, O. N. Zefirovaab

a Department of Chemistry, M.V. Lomonosov Moscow State University, Moscow, Russian Federation
b Institute of Physiologically Active Compounds, Federal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, Chernogolovka, Moscow Region, Russian Federation
c Institute of Biological Sciences, Cell Biology and Biosystems Technology, University of Rostock, Rostock, Germany
d Volzhsky Polytechnic Institute (Branch), Volgograd State Technical University, Volzhsky, Russian Federation
e Volgograd State Technical University, Volgograd, Russian Federation

Abstract: New analogues of anticancer agent tubuloclustin N-[7-(adamantan-1-yloxy)-7-heptanoyl]-N-deacetylcolchicine with ether moiety in the linker between colchicine and adamantine fragments were synthesized from w-(adamantan-1-yloxy)alkan- 1-ols. These compounds effectively inhibited growth of human lung carcinoma cell line A549 (IC50=5–15.5nM), induced both apoptosis and formation of tubulin clusters. The conjugates lacking ester carbonyl in the linker exhibit improved metabolic stability and are promising for further cytotoxicity studies in vivo.

Keywords: adamantane, dehydroadamantane, colchicine, tubuloclustin, metabolic stability, tubulin, colchicine binding site, depolymerisation of microtubules, carcinoma A549 cell line..

Language: English

DOI: 10.1016/j.mencom.2020.01.035



© Steklov Math. Inst. of RAS, 2025